Big Move For Proteostasis Therapeutics, Inc.
Thu, Dec 05, 2019 at 05:30 PM
Proteostasis Therapeutics, Inc. (PTI:NASDAQ) soared at $3.79, representing a gain of 35.4%. On Wed 04 Dec 19, PTI:NASDAQ touched a New 2-Week High of $2.8. The stock appeared on our News Catalysts scanner on Tue 03 Dec 19 at 08:18 AM in the 'MISCELLANEOUS' category. From Wed 13 Nov 19, the stock recorded 71.43% Up Days and 73.33% Green Days
About Proteostasis Therapeutics, Inc. (PTI:NASDAQ)
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Top 10 Gainers:
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 78.78%
- QuickLogic Corporation (QUIK:NASDAQ), 36.08%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 35.36%
- SecureWorks Corp. (SCWX:NASDAQ), 29.45%
- Iterum Therapeutics plc (ITRM:NASDAQ), 29.09%
- Express, Inc. (EXPR:NYSE), 27.88%
- BIO-key International, Inc. (BKYI:NASDAQ), 27.27%
- Duluth Holdings Inc. (DLTH:NASDAQ), 24.58%
- DermTech, Inc. (DMTK:NASDAQ), 24.21%
- Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ), 21.52%